Diffuse proliferative glomerulonephritis in behçet's syndrome

Rheumatology

Volumn 30, Issue 1, 1991, Pages 63-64

  Hamuryudan, V ^c   Yurdakul, S ^c   Kural, A R ^a   Ince, U ^b   Yazici, H ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE HOSPITAL   (Turkey)

^c NONE

Author keywords

Beh et's syndrome; Glomerulonephritis; Renal disease

Indexed keywords

IMMUNOGLOBULIN M;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; DIAGNOSIS; FEMALE; GLOMERULONEPHRITIS; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; PRIORITY JOURNAL; PROTEINURIA;

ADULT; BEHCET SYNDROME; BIOPSY; CASE REPORT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN M; KIDNEY; STAINING AND LABELING;

EID: 0025847676     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/30.1.63     Document Type: Article

References (19)

1. O’Duffy JD, Carney JA, Deodhar S. Behçet’s disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med 1971;75:561–70.
2. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubay O, Ohokubo T. Pathologic features of Behçet’s syndrome. A review of Japanese autopsy registry data. Human Pathol 1985;16:790–5.
3. Gamble CN, Wisner KB, Shapiro RF. The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behçet’s disease. Am J Med 1979;66:1031–9.
4. Fukuda Y, Uekusa T, Watanabe I, Hayashi H. Pathological studies of Behçet’s disease. In: Lehner T, Barnes CG, eds. Recent advances in Behçet’s disease. London: Royal Society of Medicine Services, 1986;103:105–15.
5. Tüzün Y, Yazıcı H, Pazarl H, Yalçin B, Yurdakul S, Müftüoǧlu A. The usefulness of the nonspecific skin hyperreactivity (the pathergy test) in Behçet’s disease in Turkey. Acta Derm Venereol (Stockh) 1979;59:77–9.
6. Kansu E, Deghin S, Cantor RI. The expanding spectrum of Behçet’s syndrome. JAMA 1977;237:1855–6.
7. Wilkey D, Yocum DE, Oberley TD, Sundstrom WR, Kare L. Budd–Chiari syndrome and renal failure in Behçet’s disease. Am J Med 1983;75:541–50.
8. Yudis M. Nephropathy with Behçet’s syndrome. Arch Intern Med 1979;139:602–3.
9. Yurdakul S, Tüzüner N, Yurdakul I, Hamuryudan V, Yazici H. Amyloidosis in Behçet’s Syndrome. In press.
10. Rosenthal T, Bank H, Aladjem M, David R, Gafni J. Systemic amyloidosis in Behçet’s disease. Ann Intern Med 1975;83:220–3.
11. Landwehr DM, Cooke CL, Rodriguez MD. Rapidly progressive glomerulonephritis in Behçet’s syndrome. JAMA 1980;244:1709–11.
12. Chajek T, Fainaru M. Behçet’s disease. Report of 41cases and a review of the literature. Medicine 1975;54:179–87.
13. Rosenthal T, Weiss P, Gafni J. Renal involvement inBehçet’s disease. Arch Intern Med 1978;138:1122–4.
14. Oshima Y, Shimizo T, Yokoham R, et al. Clinical studies on Behçet’s syndrome. Ann Rheum Dis 1963;22:36–45.
15. Williams DG, Lehner T. Renal manifestations of Behçet’s syndrome. In: Lehner T, Barnes CG, eds. Behçet’s syndrome. New York: Academic Press, 1979;259–64.
16. Olsson PJ, Gaffney E, Alexander RW, Mars DR, Fuller TJF. Proliferative glomerulonephritis with crescent formation in Behçet’s syndrome. Arch Intern Med 1980;140:713–14.
17. Finucane P, Doyle CT, Ferris JB. Behçet’s syndrome with myositis and glomerulonephritis. Br J Rheumatol 1985;24:372–5.
18. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725–38.
19. Lehner T, Batchelor JR, Challacombe SJ, Kennedy I. An immunogenetic basis for the tissue involvement in Behçet’s syndrome. Immunology 1979;37:895–900